$129.45
2.87% yesterday
NYSE, Oct 15, 10:08 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$129.45
-1.88 1.43% 1M
+3.23 2.56% 6M
+16.34 14.45% YTD
+13.40 11.55% 1Y
+25.93 25.05% 3Y
+22.13 20.62% 5Y
+87.58 209.17% 10Y
+109.09 535.84% 20Y
NYSE, Closing price Wed, Oct 15 2025
-3.82 2.87%

Key metrics

Basic
Market capitalization
$232.0b
Enterprise Value
$238.1b
Net debt
$6.2b
Cash
$7.3b
Shares outstanding
1.7b
Valuation (TTM | estimate)
P/E
16.7 | 25.7
P/S
5.4 | 5.1
EV/Sales
5.5 | 5.3
EV/FCF
35.1
P/B
4.6
Dividends
DPS
$2.24
Yield 1Y | 5Y
1.7% | 1.8%
Growth 1Y | 5Y
7.7% | 11.2%
Payout 1Y | 3Y
29.2% | 42.0%
Increased
11 Years
Financials (TTM | estimate)
Revenue
$43.1b | $45.1b
EBITDA
$9.5b | $12.0b
EBIT
$7.7b | $10.5b
Net Income
$14.0b | $9.0b
Free Cash Flow
$6.8b
Growth (TTM | estimate)
Revenue
5.9% | 7.6%
EBITDA
9.1% | 35.6%
EBIT
13.8% | 50.6%
Net Income
151.6% | -32.5%
Free Cash Flow
19.8%
Margin (TTM | estimate)
Gross
56.2%
EBITDA
22.0% | 26.6%
EBIT
17.9%
Net
32.4% | 20.0%
Free Cash Flow
15.7%
Financial Health
Equity Ratio
58.6%
Return on Equity
28.1%
ROCE
10.9%
ROIC
19.2%
Debt/Equity
0.3
More
EPS
$8.0
FCF per Share
$3.9
Short interest
1.1%
Employees
114k
Rev per Employee
$370.0k
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

35 Analysts have issued a Abbott Laboratories forecast:

23x Buy
66%
12x Hold
34%

Analyst Opinions

35 Analysts have issued a Abbott Laboratories forecast:

Buy
66%
Hold
34%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
43,109 43,109
6% 6%
100%
- Direct Costs 18,882 18,882
4% 4%
44%
24,227 24,227
7% 7%
56%
- Selling and Administrative Expenses 11,918 11,918
6% 6%
28%
- Research and Development Expense 2,837 2,837
9% 9%
7%
9,472 9,472
9% 9%
22%
- Depreciation and Amortization 1,775 1,775
8% 8%
4%
EBIT (Operating Income) EBIT 7,697 7,697
14% 14%
18%
Net Profit 13,979 13,979
152% 152%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Neutral
Seeking Alpha
about 5 hours ago
Abbott Laboratories (NYSE:ABT ) Q3 2025 Earnings Call October 15, 2025 9:00 AM EDT Company Participants Michael Comilla - Vice President of Investor Relations. Robert Ford - Chairman of the Board, President & CEO Philip Boudreau - CFO & Executive VP of Finance Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Robert Marcus - JPMorgan Chase & Co, Resea...
Positive
The Motley Fool
about 8 hours ago
CCLA Investment Management disclosed a purchase of 66,275 shares of Abbott Laboratories (ABT -3.20%) , estimated at ~$8.70 million based on the quarterly average price, in its SEC filing for the period ended September 30, 2025, filed on October 14, 2025.
Positive
Proactive Investors
about 9 hours ago
Abbott Laboratories (NYSE:ABT) reported steady growth in the third quarter, with sales rising 6.9% to $11.37 billion, slightly below estimates of $11.4 billion, and adjusted earnings per share matching expectations at $1.30. The company's results were driven by broad-based strength across Abbott's medical devices and diagnostics businesses, even as COVID-19 testing-related revenue continued to ...
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today